US Patent 8765751 Compounds useful as inhibitors of ATR kinase

Patent 8765751 was granted and assigned to Vertex Pharmaceuticals on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Vertex Pharmaceuticals

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8765751

Patent Inventor Names

Jean-Damien Charrier0

Christopher John Davis0

John Studley0

Stephen Clinton Young0

Date of Patent

July 1, 2014

Patent Application Number

13631730

Date Filed

September 28, 2012

Patent Citations Received

‌

US Patent 11787781 Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)

Patent Primary Examiner

‌

My-Chau T. Tran

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8765751 Compounds useful as inhibitors of ATR kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API